TY - JOUR
T1 - ERS/EAACI statement on adherence to international adult asthma guidelines
AU - Mathioudakis, Alexander G.
AU - Tsilochristou, Olympia
AU - Adcock, Ian M.
AU - Bikov, Andras
AU - Bjermer, Leif
AU - Clini, Enrico
AU - Flood, Breda
AU - Herth, Felix
AU - Horvath, Ildiko
AU - Kalayci, Omer
AU - Papadopoulos, Nikolaos G.
AU - Ryan, Dermot
AU - Garcia, Silvia Sanchez
AU - Correia-De-sousa, Jaime
AU - Tonia, Thomy
AU - Pinnock, Hillary
AU - Agache, Ioana
AU - Janson, Christer
N1 - Publisher Copyright:
© The authors 2021.
PY - 2021/9/1
Y1 - 2021/9/1
N2 - Guidelines aim to standardise and optimise asthma diagnosis and management. Nevertheless, adherence to guidelines is suboptimal and may vary across different healthcare professional (HCP) groups. Further to these concerns, this European Respiratory Society (ERS)/European Academy of Allergy and Clinical Immunology (EAACI) statement aims to: 1) evaluate the understanding of and adherence to international asthma guidelines by HCPs of different specialties via an international online survey; and 2) assess strategies focused at improving implementation of guideline-recommended interventions, and compare process and clinical outcomes in patients managed by HCPs of different specialties via systematic reviews. The online survey identified discrepancies between HCPs of different specialties which may be due to poor dissemination or lack of knowledge of the guidelines but also a reflection of the adaptations made in different clinical settings, based on available resources. The systematic reviews demonstrated that multifaceted quality improvement initiatives addressing multiple challenges to guidelines adherence are most effective in improving guidelines adherence. Differences in outcomes between patients managed by generalists or specialists should be further evaluated. Guidelines need to consider the heterogeneity of real-life settings for asthma management and tailor their recommendations accordingly. Continuous, multifaceted quality improvement processes are required to optimise and maintain guidelines adherence. Validated referral pathways for uncontrolled asthma or uncertain diagnosis are needed.
AB - Guidelines aim to standardise and optimise asthma diagnosis and management. Nevertheless, adherence to guidelines is suboptimal and may vary across different healthcare professional (HCP) groups. Further to these concerns, this European Respiratory Society (ERS)/European Academy of Allergy and Clinical Immunology (EAACI) statement aims to: 1) evaluate the understanding of and adherence to international asthma guidelines by HCPs of different specialties via an international online survey; and 2) assess strategies focused at improving implementation of guideline-recommended interventions, and compare process and clinical outcomes in patients managed by HCPs of different specialties via systematic reviews. The online survey identified discrepancies between HCPs of different specialties which may be due to poor dissemination or lack of knowledge of the guidelines but also a reflection of the adaptations made in different clinical settings, based on available resources. The systematic reviews demonstrated that multifaceted quality improvement initiatives addressing multiple challenges to guidelines adherence are most effective in improving guidelines adherence. Differences in outcomes between patients managed by generalists or specialists should be further evaluated. Guidelines need to consider the heterogeneity of real-life settings for asthma management and tailor their recommendations accordingly. Continuous, multifaceted quality improvement processes are required to optimise and maintain guidelines adherence. Validated referral pathways for uncontrolled asthma or uncertain diagnosis are needed.
U2 - 10.1183/16000617.0132-2021
DO - 10.1183/16000617.0132-2021
M3 - Review article
C2 - 34526316
AN - SCOPUS:85115731226
SN - 0905-9180
VL - 30
JO - European Respiratory Review
JF - European Respiratory Review
IS - 161
M1 - 210132
ER -